Lauren Rodgers, MD
Obstetrics & Gynecology · Oxon Hill, MDNPI 1073502548
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,912 of the $3,082 with a category attached, or 62.0%. 21 manufacturers reported payments, led by Scynexis, Inc. at 37.7% of the total. Reporting peaked in 2022 at $1,596 and has fallen 87.9% since, to $192 in 2025.
Across 96 payments — averaging $32.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Scynexis, Inc.$1K
- AbbVie$558
- Astellas Pharma US Inc$325
- Mylan Pharmaceuticals Inc.$250
- Exeltis, USA Inc.$118
- Dysis Medical, Inc.$97
- plus $572 from 15 others
What the payments were for
- Consulting fees$1,00032%
- Food & beverage$1,91262%
- Education$1706%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Scynexis, Inc. | 3 | $1,163 |
| AbbVie(2 entities) | 31 | $558 |
| Astellas Pharma US Inc | 11 | $325 |
| Mylan Pharmaceuticals Inc. | 12 | $250 |
| Exeltis, USA Inc. | 7 | $118 |
| Dysis Medical, Inc. | 3 | $97 |
| Avion Pharmaceuticals | 5 | $94 |
| Exact Sciences | 3 | $77 |
| Bayer | 2 | $59 |
| Evofem Biosciences, Inc. | 4 | $57 |
| Hologic Sales And Service, LLC | 3 | $54 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| Myovant Sciences Inc. | 2 | $34 |
| Aspira Women's Health Inc | 1 | $24 |
| Myriad Women's Health, Inc. | 1 | $23 |
| Baxter Healthcare | 1 | $22 |
| Coopersurgical, Inc. | 1 | $20 |
| Optumhealth Care Solutions, LLC | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $19 |
| Novum Pharma, LLC | 1 | $15 |
| Lupin Inc. | 1 | $11 |
How this compares
$3,082 in reported general payments places this provider in the 80th percentile of 842 obstetrics & gynecology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 97 | $2,377 |
| Medroxyprogesterone Acetate | 30 | $760 |
| Nystatin | 28 | $705 |
| Metronidazole | 35 | $643 |
| ValacyclovirValacyclovir Hcl | 16 | $613 |
| Fluconazole | 14 | $37 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Oxon Hill
- Otis StittSilver Spring$641K
- Danielle ShillerBaltimore$221K
- Matthew ReevesChevy Chase$149K
- Karen WangBaltimore$91K
- Rebecca StoneBaltimore$88K
- Abigail GregoryOakland$63K
- Christina EnzmannBaltimore$63K
- Lisa RarickChesapeake Beach$54K
- Logan PetersonBethesda$52K
- Latasha MurphyBaltimore$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.